5 Types of Lymphoma Clinical Studies | Page 4 of 5

There are many different reasons as to why researchers conduct lymphoma clinical trials. These can include: 1. Testing a therapy Testing a therapy, such as a drug or other medical intervention, for treating existing lymphoma. These are known as interventional trials. See which clinical trials are currently recruiting here. 2. Finding ways to stop the development of lymphoma For example through lifestyle changes, diet or medications. These are called prevention trials. Learn more about why we need clinical trials in lymphoma. 3. Evaluating ways to better diagnose lymphoma These are referred to as diagnostic and screening trials. Learn more about questions to ask before participating in a lymphoma clinical trial. 4. Studying lymphoma in a large group of people to better understand it as a health issue This is known as an observational trial or a non-interventional study. So, what happens when a lymphoma clinical trial ends? 5. Examining ways to improve the comfort and quality of life for people with lymphoma These are often called supportive care trials or quality of life trials. In the case of new treatments (interventional trials), three separate trial phases are required by U.S. Food and Drug Administration (FDA), or if the trial is not in the United States, those phases are required by the equivalent governing bodies of the country the trial is being conducted in. Learn some reasons why you should participate in a lymphoma clinical trial. Lymphoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Leave a Comment Cancel reply